Literature DB >> 26454311

Common Variable Immunodeficiency: Diagnosis, Management, and Treatment.

Jordan K Abbott1, Erwin W Gelfand2.   

Abstract

Common variable immunodeficiency (CVID) refers to a grouping of antibody deficiencies that lack a more specific genetic or phenotypic classification. It is the immunodeficiency classification with the greatest number of constituents, likely because of the numerous ways in which antibody production can be impaired and the frequency in which antibody production becomes impaired in human beings. CVID comprises a heterogeneous group of rare diseases. Consequently, CVID presents a significant challenge for researchers and clinicians. Despite these difficulties, both our understanding of and ability to manage this grouping of complex immune diseases has advanced significantly over the past 60 years.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody deficiency; Autoimmunity; CVID; Common variable immunodeficiency; Immune activation; Lymphoproliferation; Primary immune deficiency

Mesh:

Year:  2015        PMID: 26454311     DOI: 10.1016/j.iac.2015.07.009

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  21 in total

1.  Common Variable Immunodeficiency-Associated Inflammatory Enteropathy: The New Era of Biological Therapy.

Authors:  Cátia Arieira; Francisca Dias de Castro; Maria João Moreira; José Cotter
Journal:  GE Port J Gastroenterol       Date:  2018-02-13

2.  A 'Too Negative' ANA Test Predicts Antibody Deficiency.

Authors:  Mike Recher; Christoph T Berger; Thomas Daikeler; Christoph Hess; Ingmar A F M Heijnen
Journal:  J Clin Immunol       Date:  2016-03-10       Impact factor: 8.317

3.  Primary antibody deficiencies in Turkey: molecular and clinical aspects.

Authors:  Sinem Firtina; Yuk Yin Ng; Ozden H Ng; Ayca Kiykim; Esra Yucel Ozek; Manolya Kara; Elif Aydiner; Serdar Nepesov; Yildiz Camcioglu; Esra H Sayar; Ezgi Yalcin Gungoren; Ismail Reisli; Selda H Torun; Sule Haskologlu; Tuba Cogurlu; Aysenur Kaya; Sukru Cekic; Safa Baris; Ugur Ozbek; Ahmet Ozen; Muge Sayitoglu
Journal:  Immunol Res       Date:  2021-10-07       Impact factor: 2.829

Review 4.  Use of convalescent plasma in COVID-19 patients with immunosuppression.

Authors:  Jonathon W Senefeld; Stephen A Klassen; Shane K Ford; Katherine A Senese; Chad C Wiggins; Bruce C Bostrom; Michael A Thompson; Sarah E Baker; Wayne T Nicholson; Patrick W Johnson; Rickey E Carter; Jeffrey P Henderson; William R Hartman; Liise-Anne Pirofski; R Scott Wright; De Lisa Fairweather; Katelyn A Bruno; Nigel S Paneth; Arturo Casadevall; Michael J Joyner
Journal:  Transfusion       Date:  2021-06-01       Impact factor: 3.337

Review 5.  Idiopathic, Refractory Sweet's Syndrome Associated with Common Variable Immunodeficiency: a Case Report and Literature Review.

Authors:  Quindelyn S Cook; Carlton J Zdanski; Craig N Burkhart; Paul B Googe; Patrick Thompson; Eveline Y Wu
Journal:  Curr Allergy Asthma Rep       Date:  2019-05-14       Impact factor: 4.919

6.  Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study.

Authors:  R Ameratunga; A Jordan; A Cavadino; S Ameratunga; T Hills; R Steele; M Hurst; B McGettigan; I Chua; M Brewerton; N Kennedy; W Koopmans; Y Ahn; R Barker; C Allan; P Storey; C Slade; A Baker; L Huang; S-T Woon
Journal:  Clin Exp Immunol       Date:  2021-04-12       Impact factor: 5.732

Review 7.  Primary immunodeficiencies associated with eosinophilia.

Authors:  Behdad Navabi; Julia Elizabeth Mainwaring Upton
Journal:  Allergy Asthma Clin Immunol       Date:  2016-05-24       Impact factor: 3.406

Review 8.  Common Variable Immunodeficiency and Gastric Malignancies.

Authors:  Patrizia Leone; Angelo Vacca; Franco Dammacco; Vito Racanelli
Journal:  Int J Mol Sci       Date:  2018-02-02       Impact factor: 5.923

9.  Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic.

Authors:  M Aubignat
Journal:  Rev Neurol (Paris)       Date:  2021-06-24       Impact factor: 2.607

10.  Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus.

Authors:  Rohan Ameratunga; Wikke Koopmans; See-Tarn Woon; Euphemia Leung; Klaus Lehnert; Charlotte A Slade; Jessica C Tempany; Anselm Enders; Richard Steele; Peter Browett; Philip D Hodgkin; Vanessa L Bryant
Journal:  Clin Transl Immunology       Date:  2017-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.